Methylphenidate Hydrochloride Chewable Tablets Recalled for Failed Specifications
Rising Pharmaceuticals is voluntarily recalling Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, due to a tablet size defect. One tablet in a sealed bottle was found to be twice the size of other tablets in the same bottle.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this recall as Class II. The source explicitly states no illnesses or injuries have been reported. The defect involves a tablet size anomaly with no reported harm, making this a moderate-severity recall consistent with FDA Class II classification and voluntary precautionary action.
Plain-English summary
Rising Pharmaceuticals is voluntarily recalling Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottles, manufactured for Rising Pharmaceuticals Inc., Saddle Brook, NJ. The recall was initiated due to a market complaint reporting that a tablet in a sealed bottle was twice larger in size compared to the remaining tablets in that bottle.
The affected product is lot #25910009 with an expiration date of 01/2023. A total of 2220 100-count bottles were distributed nationwide in the USA.
This is the second complaint of this kind received regarding tablet size specifications. Consumers who have purchased this product should stop use and contact their pharmacy or healthcare provider with questions.
The recalled product
- Product
- METHYLPHENIDATE HYDROCHLORIDE (METHYLPHENIDATE HYDROCHLORIDE)
- Brand
- METHYLPHENIDATE HYDROCHLORIDE
- Manufacturer
- RISING PHARMACEUTICALS
- Hazard
- tablet-size-defect
- failed-specifications
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- lot# 25910009
- Exp 01/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · METHYLPHENIDATE HYDROCHLORIDE
- HighMethylphenidate Hydrochloride Extended-Release Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2024-07-10
- HighMethylphenidate Hydrochloride Tablets Recalled Due to Metal Contamination
FDA (Drugs) · 2023-08-02
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27